Cancer Stem Cells: From Bench to Bedside
Open Access
- 1 January 2007
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 13, 47-52
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- The paradox of response and survival in cancer therapeuticsBlood, 2006
- Aplastic anaemiaThe Lancet, 2005
- Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pumpBlood, 2004
- Does the reservoir for self-renewal stem from the ends?Oncogene, 2004
- Magnitude of Response With Myeloma Frontline Therapy Does Not Predict Outcome: Importance of Time to Progression in Southwest Oncology Group Chemotherapy TrialsJournal of Clinical Oncology, 2004
- Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid LeukemiaNew England Journal of Medicine, 2003
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences, 2003
- Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or AmplificationScience, 2001
- Short Dysfunctional Telomeres Impair Tumorigenesis in the INK4aΔ2/3 Cancer-Prone MouseCell, 1999
- Primary Bioassay of Human Tumor Stem CellsScience, 1977